Loss of Uch-L1 and Uch-L3 leads to neurodegeneration, posterior paralysis and dysphagia

Human Molecular Genetics

Volumn 10, Issue 18, 2001, Pages 1963-1970

  Kurihara, Laurie Jo ^a   Kikuchi, Tateki ^b   Wada, Keiji ^b   Tilghman, Shirley M ^a  

^a PRINCETON UNIVERSITY   (United States)

^b NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

UBIQUITIN; UBIQUITIN C TERMINAL HYDROLASE L1; UBIQUITIN C TERMINAL HYDROLASE L3; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA POSTREMA; ARTICLE; ATAXIA; CARBOXY TERMINAL SEQUENCE; CENTRAL NERVOUS SYSTEM FUNCTION; CONTROLLED STUDY; DEGENERATIVE DISEASE; DYSPHAGIA; FOOD INTAKE; GENE DELETION; GENE FUNCTION; GRACILE NUCLEUS; HISTOLOGY; HOMOZYGOSITY; LETHALITY; MEDULLA OBLONGATA; MOUSE; MOUSE MUTANT; NERVE CELL; NERVE DEGENERATION; NERVE FIBER DEGENERATION; NONHUMAN; PARALYSIS; PRIORITY JOURNAL; SOLITARY TRACT NUCLEUS; SPINAL CORD; SPINAL GANGLION; SWALLOWING;

EID: 0035444169     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/10.18.1963     Document Type: Article

References (43)

1. Ubiquitin-mediated proteolysis: Biological regulation via destruction
2. UBE3A/E6-AP mutations cause Angelman syndrome
3. Imprinting of the Angelman syndrome gene, UBE3A, is restricted to brain
4. Ubiquitin, cellular inclusions and their role in neurodegeneration
5. Impairment of the ubiquitin-proteasome system by protein aggregation
6. Ubiquitin is a common factor in intermediate filament inclusion bodies of diverse type in man, including those of Parkinson's disease, Pick's disease, and Alzheimer's disease, as well as Rosenthal fibres in cytoplasmic bodies in muscle, and mallory bodies in alcoholic liver disease
7. Ubiquitin is a component of paired helical filaments in Alzheimer's disease
8. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase
9. Degradation of α-synuclein by proteasome
10. Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice
11. Gracile axonal dystrophy (GAD), a new neurological mutant in the mouse
12. Neuropathology of gracile axonal dystrophy (GAD) mouse. An animal model of central distal axonopathy in primary sensory neurons
13. Axonal degeneration of ascending sensory neurons in gracile axonal dystrophy mutant mouse
14. Progressive degeneration of motor nerve terminals in GAD mutant mouse with hereditary sensory axonopathy
15. Abnormal ubiquitination of dystrophic axons in central nervous system of gracile axonal dystrophy (GAD) mutant mouse
16. Regulation of ubiquitin-dependent processes by deubiquitinating enzymes
17. The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase
18. Expression and functional analysis of Uch-L3 during mouse development
19. Editing of ubiquitin conjugates by an isopeptidase in the 26S proteasome
20. BAP1: A novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression
21. Deubiquitinating enzymes: A new class of biological regulators
22. Substrate specificity of deubiquitinating enzymes: Ubiquitin C-terminal hydrolases
23. Molecular cloning of cDNA coding for human PGP 9.5 protein. A novel cytoplasmic marker for neurones and neuroendocrine cells
24. Cell body remodeling during dying-back axonopathy: DRG changes during advanced disease
25. Interactions of area postrema and solitary tract in the nucleus tractus solitarius
26. Distribution of carotid sinus nerve afferent fibers to solitary tract nuclei of the cat using transganglionic transport of horseradish peroxidase
27. Brainstem projections of aortic baroreceptor afferent fibers in the rat
28. Deglutition
29. The search for the central swallowing pathway: The quest for clarity
30. The ubiquitin pathway in Parkinson's disease
31. Ubiquitin carboxyl-terminal hydrolase (PGP 9.5) is selectively present in ubiquitinated inclusion bodies characteristic of human neurodegenerative diseases
32. Identification of genes that modify ataxin-1-induced neurodegeneration
33. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice
34. SCA1 transgenic mice: A model for neurodegeneration caused by an expanded CAG trinucleotide repeat
35. Commissural nucleus of the solitary tract lesions reduce food intake and body weight gain in rats
36. Ablation of the area postrema causes exaggerated consumption of preferred foods in the rat
37. Vagotomy attenuates suppression of sham feeding induced by intestinal nutrients
38. Area postrema: Site where cholecystokinin acts to decrease food intake
39. Dysphagia caused by neurologic deficits
40. C-fos protein expression in the nucleus of the solitary tract correlates with cholecystokinin dose injected and food intake in rats
41. Genomic sequencing